¡Ö¥­¡¼¥ó¡×¤È¤¤¤Ã¤¿¼ªÌĤê¤Ï¡¢ÆÍȯÀ­ÆñÄ°¤äÃ漪±ê¤Ê¤É¤Î¼À´µ¤ä¡¢Áû²»¡¢¥¹¥È¥ì¥¹¡¢¿ç̲ÉÔ­¤Ê¤É¤ÎÍ×°ø¤ÇÀ¸¤¸¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¥¢¥á¥ê¥«¼ªÌĤ궨²ñ¤ÎÄ´ºº¤Ç¤Ï¡¢2500Ëü¿Í°Ê¾å¤ÎÀ®¿Í¤¬¼ªÌĤê¤ò´µ¤Ã¤Æ¤ª¤ê¡¢¤³¤ì¤Ë¤è¤Ã¤Æ¿Âç¤Ê¥¹¥È¥ì¥¹¤¬À¸¤¸¤¿¤ê¡¢¥Ñ¥Ë¥Ã¥¯¤Ë´Ù¤Ã¤¿¤ê¤¹¤ë¤³¤È¤¬¤¢¤ë¤È¤Î¤³¤È¡£2023ǯ3·î¤Ë¥¢¥á¥ê¥«¿©ÉÊ°åÌôÉʶÉ(FDA)¤¬¾µÇ§¤·¤¿¡ÖLenire¡×¤È¤¤¤¦ÁõÃ֤ϡ¢Àå¤òÅŵ¤Åª¤Ë»É·ã¤¹¤ë¤³¤È¤Ç¡¢¼ªÌĤ꤫¤éµ¤¤ò¤½¤é¤¹¤³¤È¤¬¤Ç¤­¤ë¤È´üÂÔ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval 

https://www.lenire.com/lenire-granted-fda-approval/

An FDA approved device offers a new treatment for ringing in the ears : Shots - Health News : NPR

https://www.npr.org/sections/health-shots/2024/04/15/1244501055/tinnitus-hearing-loss-ringing-ear-noise



Neuromod Devices Ltd.¤¬³«È¯¤·¤¿Lenire¤Ï¡¢¥¹¥Æ¥ó¥ì¥¹À½¤ÎÅŶˤòÈ÷¤¨¤¿¥×¥é¥¹¥Á¥Ã¥¯À½¤Î¥Þ¥¦¥¹¥Ô¡¼¥¹¤¬Åŵ¤Åª¤Ê»É·ã¤òÀå¤ËÍ¿¤¨¤Ä¤Ä¡¢ÉÕ°¤Î¥Ø¥Ã¥É¥Õ¥©¥ó¤«¤éÇȤ⻤ä¥È¡¼¥ó¤¬Ê¹¤³¤¨¤ë¤È¤¤¤¦ÁõÃ֤Ǥ¹¡£¤³¤ÎÁõÃÖ¤ò»ÈÍѤ¹¤ë¤³¤È¤Ç¡¢Ç¾¤ÎÃí°Õ¤ò¼ªÌĤ꤫¤é±ó¤¶¤±¤ë¤³¤È¤¬²Äǽ¤È¤Î¤³¤È¤Ç¡¢¤³¤ì¤Þ¤Ç¤ÎÄ´ºº¤Ç¤Ï¡¢Lenire¤ò»î¤·¤¿È︳¼Ô¤Î84¡ó¤¬¡Ö¾É¾õ¤¬ÂçÉý¤Ë·Ú¸º¤·¤¿¡×¤È²óÅú¤·¤Æ¤¤¤Þ¤¹¡£

¤³¤Î¼Â¸³·ë²Ì¤ò´ð¤ËFDA¤Ï2023ǯ3·î¡¢Lenire¤ò¼ªÌĤê¤Î¼£ÎťǥХ¤¥¹¤È¤·¤Æ(PDF¥Õ¥¡¥¤¥ë)¾µÇ§¤·¤Þ¤·¤¿¡£¤³¤ì¤Þ¤Ç¼ªÌĤê¤Ë¤Ï¼£ÎÅË¡¤¬¤Ê¤¯¡¢ÊäÄ°´ï¤ÎÁõÃå¤ä¥Þ¥¤¥ó¥É¥Õ¥ë¥Í¥¹ÎÅË¡¤¬ÍѤ¤¤é¤ì¤Æ¤¤¤Þ¤·¤¿¤¬¡¢¼ªÌĤê¤Î¾É¾õ¤ò·Ú¸º¤¹¤ë¤³¤È¤¬¤Ç¤­¤ë¥Ç¥Ð¥¤¥¹¤È¤·¤ÆFDA¤Î¾µÇ§¤ò¼õ¤±¤¿¤Î¤ÏLenire¤¬½é¤È¤Î¤³¤È¡£



¼ÂºÝ¤Ë¡¢¥Æ¥Í¥·¡¼½£ºß½»¤Î¥·¥ó¥¬¡¼¥½¥ó¥°¥é¥¤¥¿¡¼¤Î¥ô¥£¥¯¥È¥ê¥¢¡¦¥Ð¥ó¥¯¥¹»á¤Ï¡¢2021ǯº¢¤«¤é·ã¤·¤¤¼ªÌĤê¤Ë½±¤ï¤ì¤Æ¤¤¤Þ¤·¤¿¡£¥Ð¥ó¥¯¥¹»á¤Ï¡Ö¤Þ¤ë¤Ç¥»¥ß¤ÎÂç¹ç¾§¤¬Æ¬¤ÎÃæ¤Ë¹­¤¬¤ê¡¢²Î¤Ã¤¿¤ê²»³Ú¤òÄ°¤¤¤¿¤ê¤¹¤ë¤Î¤¬º¤Æñ¤Ë¤Ê¤ê¤Þ¤·¤¿¡×¤È¸ì¤Ã¤Æ¤¤¤Þ¤¹¡£¥Ð¥ó¥¯¥¹»á¤Ï¼ªÌĤê¤òÍÞ¤¨¤ë¤È¤¤¤¦±ÉÍÜÊä½õ¿©ÉʤòÀݼ褷¤¿¤ê¡¢±¿Æ°Î̤òÁý¤ä¤·¤¿¤ê¤È¤¤¤Ã¤¿ºö¤ò¹Ö¤¸¤Þ¤·¤¿¤¬¡¢¤É¤ì¤â¼ªÌĤê¤Î²þÁ±¤Ë¤Ï»ê¤ê¤Þ¤»¤ó¤Ç¤·¤¿¡£

¤·¤«¤·¡¢¥Ð¥ó¥¯¥¹»á¤ÏLenire¤Ë½Ð²ñ¤¤¡¢ËèÆü1»þ´Ö»ÈÍѤ¹¤ë¤³¤È¤Ç¼«¿È¤Î¼ªÌĤê¤ò·àŪ¤Ë²þÁ±¤µ¤»¤ë¤³¤È¤ËÀ®¸ù¡£¡Ö¼ªÌĤê¤Ï´°Á´¤Ë¾Ã¤¨¤¿¤ï¤±¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡¢º£¤Ç¤Ï¤Û¤È¤ó¤Éµ¤¤Ë¤Ê¤é¤Ê¤¯¤Ê¤ê¤Þ¤·¤¿¡×¤È¥Ð¥ó¥¯¥¹»á¤Ï½Ò¤Ù¤Æ¤¤¤Þ¤¹¡£



Ä°³Ð³Ø¼Ô¤Î¥Ö¥é¥¤¥¢¥ó¡¦¥Õ¥ê¥¬¡¼»á¤Ï¡Ö»ä¤¿¤Á¤Ï¡¢Ç¾¤«¤éÆþ¤Ã¤Æ¤¯¤ë½ÅÍפʾðÊó¤Ë½¸Ã椹¤ë¤è¤¦¤Ë¤Ç¤­¤Æ¤ª¤ê¡¢Lenire¤¬Àå¤òÅŵ¤Åª¤Ë»É·ã¤¹¤ë¤³¤È¤Ç¡¢Ç¾¤ÎÃí°Õ¤ò¼ªÌĤ꤫¤é±ó¤¶¤±¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¤Þ¤¿¡¢Àå¤Î¿À·Ð¤òÄ̤·¤Æ´¶¤¸¤Æ¤¤¤ë¤³¤È¤È¡¢¥Ø¥Ã¥É¥Õ¥©¥ó¤«¤éή¤ì¤ë²»¤Ë¤è¤Ã¤Æ¡¢Ç¾Æâ¤Î¥¹¥Ý¥Ã¥È¥é¥¤¥È¤¬¼ªÌĤê°Ê³°¤Ë¸þ¤±¤é¤ì¤ë¤³¤È¤Ë¤Ê¤ê¤Þ¤¹¡×¤È¸ì¤ê¤Þ¤·¤¿¡£¤Þ¤¿¡¢¥Ð¥ó¥¯¥¹»á¤Ï¡ÖLenire¤òÁõÃ夷¤¿ºÝ¤Î´¶³Ð¤Ï¡¢Âì¤Î¶á¤¯¤Ë½»¤ó¤Ç¤¤¤Æ¡¢Âì¤Î²»¤¬¾ï¤Ëʹ¤³¤¨¤Æ¤¤¤ë¤è¤¦¤Ê¤â¤Î¤Ç¤¹¡£ºÇ½é¤Ïµ¤¤Ë¤Ê¤ê¤Þ¤¹¤¬¡¢»þ´Ö¤¬¤¿¤Ä¤Ë¤Ä¤ì¤ÆÂì¤Î²»¤Ï°Õ¼±¤«¤é¾Ã¤¨¤Æ¤¤¤­¤Þ¤¹¡×¤È½Ò¤Ù¤Þ¤·¤¿¡£

°ìÊý¤ÇLenire¤Ë¤ÏÊ£¿ô¤Î²ÝÂ꤬¤¢¤ê¡¢¤½¤Î°ì¤Ä¤Ï¥³¥¹¥ÈÌ̤Ǥ¹¡£1ÂæÌó4000¥É¥ë(Ìó61Ëü±ß)¤ÎLenire¤ÏÊݸ±Å¬Íѳ°¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£

¤Þ¤¿¡¢Lenire¤Ë¤è¤ë¼£ÎŸú²Ì¤¬¤¤¤Ä¤Þ¤Ç³¤¯¤«¤âÉÔÌÀ¤Ç¡¢¤³¤ì¤Þ¤Ç¤ÎÎ×¾²»î¸³¤Ç¤Ï1ǯ´Ö¸ú²Ì¤¬»ý³¤¹¤ë¤³¤È¤¬ÌÀ¤é¤«¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¤¬¡¢¤½¤ì°Ê¹ß¼£ÎŸú²Ì¤¬»ý³¤¹¤ë¤«¤ÏÉÔÌÀ¤Ç¤¹¡£¼«¿È¤â¼ªÌĤê¤ËǺ¤Þ¤µ¤ì¤ë¥Ô¥Ã¥Ä¥Ð¡¼¥°Âç³Ø°åÎÅ¥»¥ó¥¿¡¼¤Î¥Ö¥ë¡¼¥¹¡¦¥Õ¥ê¡¼¥Þ¥ó»á¤Ï¡ÖLenire¤Î»ÈÍѤò¤ä¤á¤ë¤È¡¢¼ªÌĤê¤Î¾É¾õ¤¬ºÆȯ¤·¤Þ¤·¤¿¡×¤È¸ì¤Ã¤Æ¤¤¤Þ¤¹¡£



¤½¤ì¤Ç¤â¥Õ¥ê¡¼¥Þ¥ó»á¤Ï¡¢Lenire¤Ë¤è¤ë¼£ÎŸú²Ì¤ò¼¨¤·¤¿¸¦µæ·ë²Ì¤Ë´¶Ìäò¼õ¤±¤ë¤È¤È¤â¤Ë¡¢¼«¿È¤Î¼ªÌĤ꤬²þÁ±¤·¤¿¤³¤È¤Ë¤Ä¤¤¤Æ¡Öº£¤Þ¤Ç¤ÎǺ¤ß¤¬Á´¤Æ¼ý«¤·¤Þ¤·¤¿¡×¤Èɾ²Á¤·¤Æ¤¤¤Þ¤¹¡£